In today’s world, sponsors are evaluating trials for decentralization and ensuring they have the right technologies in place to support new ways of working with sites, researchers and patients.
Cognizant® Shared Investigator Platform (SIP), a SaaS-based clinical trials platform drives engagement and improves operational efficiencies as trials increasingly go virtual. Learn how a site-centered approach enables a clinical trial experience that is fit-for-purpose by enhancing remote site-sponsor collaboration while leveraging opportunities to integrate with more patient-centric decentralized trial technologies and strategies.
With functionality built to address the increasing decentralization of trials, Cognizant SIP is the collaboration platform that harmonizes the management of key components of clinical trial operations across industry stakeholders. In this webinar, learn from experts how to:
· Employ patient-centered decentralized clinical trials
· Facilitate remote sponsor and site collaboration on key documents
· Enable seamless workflow and document exchange between site and sponsor eTMF systems
· Reduce your administrative burden with SSO to dozens of clinical trial technologies
· Leverage standardized processes across all sponsors remotely
Remote collaboration between sponsors and sites is here to stay. Learn best practices in virtualizing your own trials and take advantage of an ever-expanding ecosystem of the technologies, sites and sponsors that support it.
Watch now to learn from our experts how to employ patient-centered decentralized clinical trials.
Vice President, Digital Health & Innovation, Chief Technology Officer, Cognizant Life Sciences
Bryan Hill is Vice President, Digital Health & Innovation within Cognizant's Life Sciences Practice, responsible for driving human-first digital solutions and transformation that yield business value. Bryan has over 25 years of experience and is a recognized thought leader within the industry regarding digital trends, emerging technologies and product design.
Associate Director, Consulting, Cognizant Life Sciences
Vishal Janani is an Associate Director within Cognizant’s Life Sciences Practice and is the Product Manager for Shared Investigator Platform (SIP). Leveraging 14 years of experience with certifications in Pharmacovigilance and Pharmacoepidemiology, he is responsible for the overall functional roadmap and driving SIP adoption with pharma companies and investigative sites.
Seven of the top fifteen global biopharmaceutical companies are on a single clinical technology platform, leveraging one environment, operating via common workflows, documents and training.
Cognizant SIP harmonizes the management of key components of clinical trials across stakeholders so the trial process can be streamlined and decentralized, improving the experience for investigators.
In the “New Normal” sponsors and sites collaborate remotely throughout the trial lifecycle by leveraging a solution that streamlines trial set-up and execution, leading to improved site experiences and faster time-to-market.
Michael Diamond/ / President/Polywop Enterprises
We will never share your info, and you can unsubscribe at any time.